Discover SKYRIZI® (risankizumab-rzaa), a biologic treatment for adults with Active Psoriatic Arthritis (PsA). See Full Safety and Prescribing Information.

How Quickly Will Skyrizi Work for Psoriatic Arthritis? If Skyrizi is working, your symptoms will start to improve over the first 1-2 months.

Mar 24, 2025 · Skyrizi (also known by its generic name risankizumab-rzaa) is a biologic medication that was approved by the FDA in April 2019 for the treatment of moderate-to …

Understanding whether Skyrizi can help with psoriatic arthritis involves exploring its mechanism of action, clinical trial results, and the broader context of treatment options. Skyrizi’s active …

2 days ago · Psoriatic arthritis is a chronic inflammatory condition that affects both the skin and joints, requiring effective management strategies to improve patient outcomes. Skyrizi is a …

Jan 25, 2022 · Psoriasis and psoriatic arthritis (PsA) are clearly closely connected, which is why some medications work for people with either diagnosis. Now psoriatic arthritis patients have …

See information for healthcare professionals on SKYRIZI for the treatment of active psoriatic arthritis in adults. See Important Safety Information and Prescribing Information.

Jun 20, 2024 · Skyrizi studies in psoriatic arthritis The Skyrizi (risankizumab-rzaa) approval for psoriatic arthritis was supported by two Phase 3, placebo controlled studies, KEEPsAKE-1 and …

Dec 8, 2025 · For people living with moderate to severe psoriatic arthritis (PsA), the gold standard for treatment is a class of medicines called biologics. You also may hear biologics referred to …

Risankizumab, sold under the brand name Skyrizi (/ skaɪˈrɪzi / sky-RIZZ-ee), is a humanized monoclonal antibody used for the treatment of plaque psoriasis, psoriatic arthritis, Crohn's …